The impact of patient age on breast cancer risk prediction models.

about

The impact of patient age on breast cancer risk prediction models.

Item

http://www.wikidata.org/entity/Q48280660

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The impact of patient age on breast cancer risk prediction models.

@en

The impact of patient age on breast cancer risk prediction models.

@nl

type

Item

label

The impact of patient age on breast cancer risk prediction models.

@en

The impact of patient age on breast cancer risk prediction models.

@nl

prefLabel

The impact of patient age on breast cancer risk prediction models.

@en

The impact of patient age on breast cancer risk prediction models.

@nl

P1476

The impact of patient age on breast cancer risk prediction models.

@en

P2093

Ahmet Acar

http://www.w3.org/2001/XMLSchema#string

Alan Semine

http://www.w3.org/2001/XMLSchema#string

Jessica Cintolo-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Kevin S Hughes

http://www.w3.org/2001/XMLSchema#string

Molly Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Simplifying clinical use of the genetic risk prediction model BRCAPRO.

Assessment of the accuracy of the Gail model in women with atypical hyperplasia.

P304

592-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TBJ.12976

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Suzanne B Coopey

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316072

http://www.w3.org/2001/XMLSchema#string